This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Mohammad Karbassi, MD; Sam Nikou, MD
Boston, Mass

Arch Ophthalmol. 1995;113(6):699-701.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Hypopyon uveitis secondary to rifabutin therapy in seven patients with acquired immunodeficiency syndrome (AIDS), reported by Saran et al¹ in the September 1994 issue of the ARCHIVES, was diagnosed during treatment for systemic Mycobacterium avium complex (MAC) infection. We found three cases of acute uveitis without hypopyon in patients with AIDS who were taking a prophylactic dosage of 300 to 450 mg/d of rifabutin.

Report of Cases.

Case 1.

A 51-year-old white homosexual man with a CD4 count of 0.02X 109/L (20/µL) but with no history of AIDS-defining opportunistic infections developed acute uveitis 14 weeks after beginning prophylaxis for MAC infection (rifabutin, 450 mg/d). Other medications included fluconazole, 200 mg/d; a steroid inhaler (beclomethasone) as needed; oxybutynin chloride, 5 mg twice a day; paroxetine hydrochloride, 20 mg/d; and acyclovir, 3200 mg/d. The patient presented with sudden onset of photophobia and pain in the left eye.

Examination of the left . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?